The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis

Arthritis and Rheumatism

Volumn 41, Issue 3, 1998, Pages 460-465

  Brown, Matthew A ^a   Kennedy, L Gail ^b   Darke, Chris ^c   Gibson, Kathryn ^a   Pile, Kevin D ^d   Shatford, Jane L ^a   Taylor, Andrew ^b   Calin, Andrei ^b   Wordsworth, B Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^c Welsh Blood Service   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA DR ANTIGEN;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BONE MARROW CELL; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0031933251     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199803)41:3<460::AID-ART12>3.3.CO;2-O     Document Type: Article

References (41)

1. Robinson WP, van der Linden SM, Khan MA, Rentsch H-U, Cats A, Russell A, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum 1989; 32:1135-41.
2. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8.
3. Brown MA, Pile KD, Kennedy LG, Calin A, Darke C, Bell J, et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996;55:268-70.
4. Brown MA, Wordsworth BP. Predisposing factors to spondyloarthropathies. Curr Opin Rheumatol 1997;9:308-14.
5. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
6. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
7. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
8. Jones SD, Steiner A, Garrett SL, Calin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 1996; 35:66-71.
9. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index. J Rheumatol 1994;21:1694-8.
10. Taylor AL, Balakrishnan C, Calin A. The development of a severity index in ankylosing spondylitis [abstract]. Br J Rheumatol 1997;36 Suppl 1:128.
11. Wordsworth BP, Allsopp CE, Young RP, Bell JI. HLA-DR typing using DNA amplification by the polymerase chain reaction and sequential hybridization to sequence-specific oligonucleotide probes. Immunogenetics 1990;32:413-8.
12. Bunce M, Fanning GC, Welsh KI. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens 1995;45:81-90.
13. Lathrop GM. Estimating genotype relative risks. Tissue Antigens 1983;22:160-6.
14. Kirkwood B. Essentials of medical statistics. Oxford: Blackwell; 1988.
15. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988;120:849-52.
16. Lewontin R. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964;49:49-67.
17. Tukey J. Exploratory data analysis. Reading (MA): Addison-Wesley; 1978.
18. Taylor AL, Balakrishnan C, Calin A. Risk factors for worse disease activity and function in ankylosing spondylitis [abstract]. Arthritis Rheum 1996;39 Suppl 9:S257.
19. Taylor AL, Balakrishnan C, Calin A. The development of reference curves for function and disability in ankylosing spondylitis [abstract]. Arthritis Rheum 1996;39 Suppl 9:S257.
20. Arnett FC Jr, Schacter BZ, Hochberg MC, Hsu SH, Bias WB. Homozygosity for HLA-B27: impact on rheumatic disease expression in two families. Arthritis Rheum 1977;20:797-804.
21. Suarez AM, Russell AS. B27 homozygosity and ankylosing spondylitis. J Rheumatol 1987;14:302-4.
22. Rubin LA, Amos CI, Wade JA, Martin JR, Bale SJ, Little AH, et al. Investigating the genetic basis for ankylosing spondylitis: linkage studies with the major histocompatibility complex region. Arthritis Rheum 1994;37:1212-20.
23. Nahal R, Gautreau C, Amor B, Berthelot J-M, Combes B, Dougados M, et al. Genetic investigation in familial spondylarthropathy with focus on HLA region using transmission disequilibrium test [abstract]. Arthritis Rheum 1996;39 Suppl 9:S122.
24. Armstrong RD, Panayi GS, Welsh KI. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosingspondylitis. Ann Rheum Dis 1983;42:142-6.
25. Reveille JD, Suarez-Almazor ME, Russell AS, Go RC, Appleyard J, Barger BO, et al. HLA in ankylosing spondvlitis: is HLA-B27 the only MHC gene involved in disease pathogenesis? Semin Arthritis Rheum 1994;23:295-309.
26. Westman P, Leirisalo-Repo M, Partanen J, Koskimies S. A comparative study of HLA genes in HLA-B27 positive ankylosing spondylitis and HLA-B27 positive peripheral reactive arthritis. Arthritis Rheum 1996;39:943-9.
27. Laivoranta S, Ilonen J, Tuokko J, Luukkainen R, Toivanen A. HLA frequencies in HLA-B27 negative patients with reactive arthritis. Clin Exp Rheumatol 1995;13:637-40.
28. Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, et al. Genetic markers may predict disease behaviour in patients with ulcerative colitis. Gastroenterology 1997;112:1845-53.
29. Mielants H, Veys EM, Cuvelier C, de Vos M. Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol 1988;2:95-105.
30. La NG, Mathieu A, Mulargia M, Carcassi C, Vacca A, Ledda A, et al. Association of the HLA-A2, CW2, B27, S31, DR2 haplotype with ankylosing spondylitis: a possible role of non-B27 factors in the disease. Dis Markers 1993;11:191-203.
31. Lopez D, Barber D, Villadangos J, Lopez de Castro J. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2. J Immunol 1993;150:2675-86.
32. Miehle W, Schattenkirchner M, Albert D, Bunge M. HLA-DR4 in ankylosing spondylitis with different patterns of joint involvement. Ann Rheum Dis 1985;44:39-44.
33. Tuokko J, Reijonen H, Ilonen J, Anttila K, Nikkari S, Mottonen T, et al. Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis. Ann Rheum Dis 1997;56:37-41.
34. Sanmarti R, Ercilla MG, Brancos MA, Cid MC, Collado A, Rotes Querol J. HLA class II antigens (DR, DQ loci) and peripheral arthritis in ankylosing spondylitis. Ann Rheum Dis 1987;46:497-500.
35. Aaron S, Miller ML, Howard J, Fraser PA, Jackson JM, Larsou MG, et al. Complementation with HLA-A and HLA-D locus alleles in ankylosing spondylitis with peripheral arthritis. J Rheumatol 1985;12:553-7.
36. Gladman DD, Anhorn KA, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol 1986;13:586-92.
37. Sakkas L, Loqueman N, Bird H, Vaughan R, Welsh K, Panayi G. HLA class II and T cell receptor gene polymorphisms in psoriatic arthritis and psoriasis. J Rheumatol 1990;17:1487-90.
38. Gladman DD, Farewell VT. The role of HLA antigens as indicators of disease progression in psoriatic arthritis: multivariate relative risk model. Arthritis Rheum 1995;38:845-50.
39. Monowarul Islam SM, Numaga J, Fujino Y, Masuda K, Ohda H, Hirata R, et al. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum 1995;38:547-50.
40. Ploski R, Maksymowych W, Førre Ø. HLA-DR8 and susceptibility to acute anterior uveitis in ankylosing spondylitis: comment on the article by Monowarul Islam et al [letter]. Arthritis Rheum 1996; 39:351.
41. Muto M, Nagai K, Mogami S, Nakano J, Sasazuki T, Asagami C. HLA antigens in Japanese patients with psoriatic arthritis. Tissue Antigens 1995;45:362-4.